CLIMARA Side Effects

6413650-8 | Unevaluable Event
on Sep 11, 2009 Female patient from GERMANY , 59 years of age, was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event. Climara dosage: 0.06mg/day.

6413635-1 | Application Site Erythema, Product Adhesion Issue
Patient was taking Climara (View Usage). Patient had the following side effects: application site erythema, product adhesion issue on Sep 01, 2009 from UNITED STATES Additional patient health information: Female patient , 35 years of age, . Climara dosage: .

6410031-8 | Application Site Pruritus, Application Site Rash
Adverse event was reported on Oct 14, 2009 by a Female patient taking Climara (View Usage) (Dosage: ) . Location: UNITED STATES , 73 years of age, After Climara was administered, patient had the following side effects: application site pruritus, application site rash.

6409988-0 | Application Site Irritation
on Aug 24, 2009 Female patient from UNITED STATES , 36 years of age, was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: application site irritation. Climara dosage: .


6409966-1 | Application Site Erythema, No Adverse Event
on Jul 27, 2009 Female patient from UNITED STATES , 35 years of age, was treated with Climara (View Usage). Patient had the following side effects: application site erythema, no adverse event. Climara dosage: .

6405497-3 | Application Site Rash
Patient was taking Climara (View Usage). After Climara was administered, patient had the following side effects: application site rash on Sep 16, 2009 from UNITED STATES Additional patient health information: Female patient , 51 years of age, . Climara dosage: 0.075mg/day Applied To Abdomen.

6403898-0 | Angina Pectoris, Breast Cancer In Situ, Heart Rate Increased, Heart Valve Incompetence, Hypertension, Menopausal Symptoms
Adverse event was reported on Oct 14, 2009 by a Female patient taking Climara (View Usage) (Dosage: .1 Mg/d, Unk) was diagnosed with menopause (What is menopause?), arthralgia, hypertension and. Location: UNITED STATES , 58 years of age, weighting 145.5 lb, Patient experienced the following unwanted or unexpected effects: angina pectoris, breast cancer in situ, heart rate increased, heart valve incompetence, hypertension, menopausal symptoms. During the same period patient was treated with HORMONES AND RELATED AGENTS (Unk, Unk) (View Hormones And Related Agents Review and Hormones And Related Agents Label ), PROPACET 100 (Unk, Unk) (View Propacet 100 Review and Propacet 100 Label ), ALPRAZOLAM (.25 Mg, Unk) (View Alprazolam Review and Alprazolam Label ), DILTIA XT (180mg/24) (View Diltia Xt Review and Diltia Xt Label ), TRAZODONE (50 Mg, Unk) (View Trazodone Review and Trazodone Label ), CARAFATE (1 G, Unk) (View Carafate Review and Carafate Label ), PREVACID (30 Mg, Unk) (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6403811-6 | Breast Cancer
on Oct 13, 2009 Female patient from UNITED STATES , 67 years of age, weighting 103.6 lb, was diagnosed with menopause (What is menopause?) and was treated with Climara (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Climara dosage: . During the same period patient was treated with ESTRACE (View Estrace Review and Estrace Label ), PROVERA (View Provera Review and Provera Label ), ESTRADERM (View Estraderm Review and Estraderm Label ), ESTROGEN (View Estrogen Review and Estrogen Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PREMARIN (View Premarin Review and Premarin Label ).

6401424-3 | Breast Cancer In Situ
on Oct 12, 2009 Female patient from UNITED STATES , 49 years of age, weighting 127.9 lb, was diagnosed with menopausal symptoms, blood cholesterol increased, hypothyroidism, osteoporosis (What is osteoporosis?), autoimmune disorder and was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: breast cancer in situ. Climara dosage: 100 Mcgg/24h. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTRATEST (Unk, Unk) (View Estratest Review and Estratest Label ), LIPITOR (Unk, Unk) (View Lipitor Review and Lipitor Label ), SYNTHROID (Total Daily Dose: 75 ?g) (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ).

6401346-8 | Application Site Inflammation, Application Site Pruritus, Device Malfunction
Patient was taking Climara (View Usage). Patient experienced the following unwanted or unexpected effects: application site inflammation, application site pruritus, device malfunction on Sep 14, 2009 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Climara dosage: .

6394742-9 | Muscle Strain, No Adverse Event
Adverse event was reported on Sep 08, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) . Location: UNITED STATES , 61 years of age, Patient had the following side effects: muscle strain, no adverse event.

6391712-1 | Breast Swelling, Lymphadenopathy
on Aug 07, 2009 Female patient from UNITED STATES , 64 years of age, was diagnosed with menopause (What is menopause?) and was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: breast swelling, lymphadenopathy. Climara dosage: . During the same period patient was treated with TYLENOL (Once A Month Or Once Very 6 Months) (View Tylenol Review and Tylenol Label ).

6380358-7 | Abdominal Pain, Anxiety, Benign Breast Neoplasm, Breast Cancer Stage Ii, Breast Mass, Deformity, Hot Flush, Nausea
on Sep 23, 2009 Female patient from UNITED STATES , 51 years of age, weighting 189.6 lb, was diagnosed with menopausal symptoms, urticaria, type 2 diabetes mellitus and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), benign breast neoplasm, breast cancer stage ii, breast mass, deformity, hot flush, nausea (What is nausea?). Climara dosage: .5 Mg/d, Cont. During the same period patient was treated with PREMPRO (.625/2.5 Mg/d, 1x/day) (View Prempro Review and Prempro Label ), PROVERA (Unit Dose: 2.5 Mg) (View Provera Review and Provera Label ), PREFEST (Unk, Unk) (View Prefest Review and Prefest Label ), ACTIVELLA (Unk, Unk) (View Activella Review and Activella Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ATARAX (Unk, Unk) (View Atarax Review and Atarax Label ), HYDROXYZINE HCL (Total Daily Dose: 40 Mg) (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), METFORMIN HCL (Total Daily Dose: 1000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6378839-5 | Rash
Patient was taking Climara (View Usage). Patient had the following side effects: rash (What is rash?) on Jul 21, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, . Climara dosage: .

6377107-5 | Breast Tenderness, Endometrial Disorder, Hot Flush, Vaginal Haemorrhage
Adverse event was reported on May 21, 2009 by a Female patient taking Climara (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, weighting 149.9 lb, After Climara was administered, patient had the following side effects: breast tenderness, endometrial disorder, hot flush, vaginal haemorrhage. During the same period patient was treated with PROMETRIUM (12 Days Per Month) (View Prometrium Review and Prometrium Label ).

6376901-4 | Adverse Event, Mammogram Abnormal
on Aug 25, 2009 Female patient from UNITED STATES , 57 years of age, was diagnosed with vulvovaginal dryness and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, mammogram abnormal. Climara dosage: 0.025 Mg/day.

6370391-3 | Application Site Rash
on Aug 04, 2009 Female patient from UNITED STATES , 51 years of age, was treated with Climara (View Usage). Patient had the following side effects: application site rash. Climara dosage: 0.075mg/day Applied To Abdomen.

6359956-2 | Confusional State, Headache, Malaise, Palpitations, Product Quality Issue
Patient was taking Climara (View Usage). After Climara was administered, patient had the following side effects: confusional state, headache (What is headache?), malaise, palpitations, product quality issue on Jun 01, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 134.5 lb, was diagnosed with hysterectomy (What is hysterectomy?), headache (What is headache?) and. Climara dosage: Continuous Delivery For Once Weekly Application. During the same period patient was treated with ALKA SELTZER (View Alka Seltzer Review and Alka Seltzer Label ), IMITREX (View Imitrex Review and Imitrex Label ), ATIVAN (View Ativan Review and Ativan Label ), AMBIEN (View Ambien Review and Ambien Label ).

6359274-2 | Confusional State, Headache, Malaise, Palpitations, Product Quality Issue
Adverse event was reported on Jun 01, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) was diagnosed with hysterectomy (What is hysterectomy?), headache (What is headache?) and. Location: UNITED STATES , 56 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: confusional state, headache (What is headache?), malaise, palpitations, product quality issue. During the same period patient was treated with ALKA SELTZER (View Alka Seltzer Review and Alka Seltzer Label ), IMITREX (View Imitrex Review and Imitrex Label ), ATIVAN (View Ativan Review and Ativan Label ), AMBIEN (View Ambien Review and Ambien Label ).

6356154-3 | Hot Flush
on Jul 15, 2009 Female patient from UNITED STATES , 54 years of age, was treated with Climara (View Usage). Patient had the following side effects: hot flush. Climara dosage: .

6356112-9 | Abdominal Distension, Flatulence
on Jul 07, 2009 Female patient from UNITED STATES , 78 years of age, was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: abdominal distension, flatulence. Climara dosage: Continuous Delivery For Once Weekly Application.

6354239-9 | Application Site Rash
Patient was taking Climara (View Usage). Patient experienced the following unwanted or unexpected effects: application site rash on Aug 12, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, . Climara dosage: .

6347091-9 | Hot Flush
Adverse event was reported on Jul 27, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) . Location: UNITED STATES , 57 years of age, Patient had the following side effects: hot flush. During the same period patient was treated with PROVERA (View Provera Review and Provera Label ).

6343495-9 | Anxiety, Depression, Feeling Hot
on Aug 06, 2009 Female patient from UNITED STATES , 65 years of age, weighting 127.9 lb, was diagnosed with menopausal symptoms and was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), feeling hot. Climara dosage: Continuous Delivery For Once Weekly Application. During the same period patient was treated with PROGESTERONE (NATURAL) (View Progesterone (natural) Review and Progesterone (natural) Label ).

6336054-5 | Breast Mass, Cholecystitis Chronic, Cholelithiasis, Gastritis, Ovarian Cancer, Umbilical Hernia, Uterine Leiomyoma
on Aug 28, 2009 Female patient from UNITED STATES , 52 years of age, weighting 211.6 lb, was diagnosed with menopausal symptoms, hypertension, blood cholesterol increased and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: breast mass, cholecystitis chronic, cholelithiasis, gastritis, ovarian cancer, umbilical hernia, uterine leiomyoma. Climara dosage: Unk Mg/d, Cont. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), ASPIRIN (Unk, Unk) (View Aspirin Review and Aspirin Label ), ATENOLOL (Unit Dose: 50 Mg) (View Atenolol Review and Atenolol Label ), LISINOPRIL (Unk, Unk) (View Lisinopril Review and Lisinopril Label ), PRAVACHOL (Unit Dose: 40 Mg) (View Pravachol Review and Pravachol Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ). Patient was hospitalized.

6336017-X | Adenomyosis, Blood Cholesterol Increased, Low Density Lipoprotein Increased, Ovarian Granulosa-theca Cell Tumour, Smear Cervix Abnormal, Uterine Leiomyoma
Patient was taking Climara (View Usage). Patient had the following side effects: adenomyosis, blood cholesterol increased, low density lipoprotein increased, ovarian granulosa-theca cell tumour, smear cervix abnormal, uterine leiomyoma on Aug 24, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 152.1 lb, was diagnosed with menopausal symptoms, libido decreased and. Climara dosage: .025 Mg/d, Cont. During the same period patient was treated with PREMARIN (.625 Mg, Unk) (View Premarin Review and Premarin Label ), CYCRIN (5 And 2.5 Mg, Unk) (View Cycrin Review and Cycrin Label ), PROMETRIUM (100 Mg, Unk) (View Prometrium Review and Prometrium Label ), ACTIVELLA (Unk, Unk) (View Activella Review and Activella Label ), MEDROXYPROGESTERONE ACETATE (5 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), PROVERA (View Provera Review and Provera Label ), TESTOSTERONE (0.5cc) (View Testosterone Review and Testosterone Label ), DHEA (View Dhea Review and Dhea Label ). Patient was hospitalized.

6336012-0 | Breast Cancer In Situ
Adverse event was reported on Aug 28, 2009 by a Female patient taking Climara (View Usage) (Dosage: 100 Mcgg/24h) was diagnosed with menopausal symptoms, blood cholesterol increased, osteoporosis (What is osteoporosis?), thyroid disorder and. Location: UNITED STATES , 49 years of age, weighting 127.9 lb, After Climara was administered, patient had the following side effects: breast cancer in situ. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTRATEST (Unk, Unk) (View Estratest Review and Estratest Label ), LIPITOR (Unk, Unk) (View Lipitor Review and Lipitor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ).

6336000-4 | Arthritis, Breast Cancer, Memory Impairment, Post Procedural Cellulitis
on Aug 24, 2009 Female patient from UNITED STATES , 54 years of age, weighting 163.1 lb, was diagnosed with menopause (What is menopause?), hot flush, hypertension, hypothyroidism, blood cholesterol increased, depression (What is depression?) and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), breast cancer (What is breast cancer?), memory impairment, post procedural cellulitis. Climara dosage: Used 1/2 A Patch At Times In 1997. During the same period patient was treated with PROMETRIUM (1-12 Of Every Month) (View Prometrium Review and Prometrium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), NORVASC (View Norvasc Review and Norvasc Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), ZOCOR (View Zocor Review and Zocor Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6334533-8 | Intervertebral Disc Operation, No Adverse Event
on Jun 24, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Climara (View Usage). Patient had the following side effects: intervertebral disc operation, no adverse event. Climara dosage: Continuous Delivery For Once Weekly Application.

6334532-6 | Hot Flush
Patient was taking Climara (View Usage). After Climara was administered, patient had the following side effects: hot flush on Jul 31, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, . Climara dosage: Continuous Delivery For Once Weekly Application.

6330458-2 | Abdominal Pain, Anxiety, Breast Cancer Stage Ii, Deformity, Hot Flush, Nausea, Post Procedural Cellulitis, Seroma
Adverse event was reported on Aug 21, 2009 by a Female patient taking Climara (View Usage) (Dosage: .5 Mg/d, Cont) was diagnosed with menopausal symptoms, urticaria, type 2 diabetes mellitus and. Location: UNITED STATES , 51 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), breast cancer stage ii, deformity, hot flush, nausea (What is nausea?), post procedural cellulitis, seroma. During the same period patient was treated with PREMPRO (.625/2.5 Mg/d, 1x/day) (View Prempro Review and Prempro Label ), PROVERA (Unit Dose: 2.5 Mg) (View Provera Review and Provera Label ), PREFEST (Unk, Unk) (View Prefest Review and Prefest Label ), ACTIVELLA (Unk, Unk) (View Activella Review and Activella Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ATARAX (Unk, Unk) (View Atarax Review and Atarax Label ), HYDROXYZINE HCL (Total Daily Dose: 40 Mg) (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), METFORMIN HCL (Total Daily Dose: 1000 Mg) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6330455-7 | Breast Cancer In Situ
on Aug 19, 2009 Female patient from UNITED STATES , 49 years of age, weighting 127.9 lb, was diagnosed with menopausal symptoms, blood cholesterol increased, osteoporosis (What is osteoporosis?), thyroid disorder and was treated with Climara (View Usage). Patient had the following side effects: breast cancer in situ. Climara dosage: 100 Mcgg/24h. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTRATEST (Unk, Unk) (View Estratest Review and Estratest Label ), LIPITOR (Unk, Unk) (View Lipitor Review and Lipitor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ).

6321833-0 | No Adverse Event
on Jun 09, 2009 Female patient from UNITED STATES , weighting 105.8 lb, was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: no adverse event. Climara dosage: Continuous Delivery For Once Weekly Application.

6321808-1 | Device Adhesion Issue, Rash
Patient was taking Climara (View Usage). Patient experienced the following unwanted or unexpected effects: device adhesion issue, rash (What is rash?) on Aug 21, 2009 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 236.6 lb, was diagnosed with menopausal symptoms and. Climara dosage: 0.025 1x Weeks Transdermal. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ).

6321653-7 | Breast Mass, Cholecystitis Chronic, Cholelithiasis, Gastritis, Ovarian Cancer, Umbilical Hernia, Uterine Leiomyoma
Adverse event was reported on Aug 18, 2009 by a Female patient taking Climara (View Usage) (Dosage: Unk Mg/d, Cont) was diagnosed with menopausal symptoms, hypertension, blood cholesterol increased and. Location: UNITED STATES , 52 years of age, weighting 211.6 lb, Patient had the following side effects: breast mass, cholecystitis chronic, cholelithiasis, gastritis, ovarian cancer, umbilical hernia, uterine leiomyoma. During the same period patient was treated with PREMPRO (0.625/2.5 Mg, Unk) (View Prempro Review and Prempro Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (1 Mg, Unk) (View Estrace Review and Estrace Label ), ASPIRIN (Unk, Unk) (View Aspirin Review and Aspirin Label ), ATENOLOL (Unit Dose: 50 Mg) (View Atenolol Review and Atenolol Label ), LISINOPRIL (Unk, Unk) (View Lisinopril Review and Lisinopril Label ), PRAVACHOL (Unit Dose: 40 Mg) (View Pravachol Review and Pravachol Label ), CARDIZEM CD (View Cardizem Cd Review and Cardizem Cd Label ). Patient was hospitalized.

6321652-5 | Abdominal Pain, Anxiety, Breast Cancer Stage Ii, Deformity, Hot Flush, Nausea, Post Procedural Cellulitis, Seroma
on Aug 18, 2009 Female patient from UNITED STATES , 51 years of age, weighting 189.6 lb, was diagnosed with menopausal symptoms, urticaria, type 2 diabetes mellitus and was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), breast cancer stage ii, deformity, hot flush, nausea (What is nausea?), post procedural cellulitis, seroma. Climara dosage: .5 Mg/d, Cont. During the same period patient was treated with PREMPRO (.625/2.5 Mg/d, 1x/day) (View Prempro Review and Prempro Label ), PROVERA (Unit Dose: 2.5 Mg) (View Provera Review and Provera Label ), PREFEST (Unk, Unk) (View Prefest Review and Prefest Label ), ACTIVELLA (Unk, Unk) (View Activella Review and Activella Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ATARAX (Unk, Unk) (View Atarax Review and Atarax Label ), HYDROXYZINE HCL (Total Daily Dose: 40 Mg) (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ), METFORMIN (Total Daily Dose: 1000 Mg) (View Metformin Review and Metformin Label ). Patient was hospitalized.

6314627-3 | Application Site Papules, Application Site Rash
on May 28, 2009 Female patient from UNITED STATES , weighting 119.0 lb, was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: application site papules, application site rash. Climara dosage: Continuous Delivery For Once Weekly Application.

6311252-5 | Postmenopausal Haemorrhage
Patient was taking Climara (View Usage). Patient had the following side effects: postmenopausal haemorrhage on Jun 19, 2009 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 169.8 lb, was diagnosed with menopause (What is menopause?) and. Climara dosage: Total Daily Dose: 0.05 Mg. During the same period patient was treated with VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), TYLENOL W/ CODEINE (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

6309496-1 | Hot Flush
Adverse event was reported on May 12, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) was diagnosed with hot flush, migraine (What is migraine?), bladder disorder, multiple allergies, nausea (What is nausea?) and. Location: UNITED STATES , 64 years of age, After Climara was administered, patient had the following side effects: hot flush. During the same period patient was treated with FIORICET (View Fioricet Review and Fioricet Label ), DETROL LA (View Detrol La Review and Detrol La Label ), ALLEGRA (View Allegra Review and Allegra Label ), VISTARIL (View Vistaril Review and Vistaril Label ).

6300921-9 | Dermatitis Contact
on Aug 06, 2009 Female patient from UNITED STATES , 63 years of age, was diagnosed with hot flush, menopause (What is menopause?) and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis contact. Climara dosage: 0.0375 1qwk.

6288188-1 | Abdominal Pain Upper, Breast Cancer In Situ, Cervical Dysplasia, Cervix Carcinoma, Depression, Dermal Cyst, Impaired Work Ability, Morton's Neuroma
on Jul 23, 2009 Female patient from UNITED STATES , 48 years of age, weighting 167.6 lb, was treated with Climara (View Usage). Patient had the following side effects: abdominal pain upper, breast cancer in situ, cervical dysplasia, cervix carcinoma, depression (What is depression?), dermal cyst, impaired work ability, morton's neuroma. Climara dosage: .05 Mg/day Continuous. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ). Patient was hospitalized.

6277611-4 | Anxiety, Depression, Feeling Hot
Patient was taking Climara (View Usage). After Climara was administered, patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), feeling hot on May 05, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 127.9 lb, was diagnosed with menopausal symptoms and. Climara dosage: Continuous Delivery For Once Weekly Application. During the same period patient was treated with PROGESTERONE (NATURAL) (View Progesterone (natural) Review and Progesterone (natural) Label ).

6277582-0 | Dizziness, Nausea
Adverse event was reported on May 04, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) . Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?).

6277554-6 | Breast Enlargement, Breast Tenderness, Pain In Extremity
on Apr 27, 2009 Female patient from UNITED STATES , 46 years of age, was treated with Climara (View Usage). Patient had the following side effects: breast enlargement, breast tenderness, pain in extremity. Climara dosage: .

6275190-9 | Breast Cancer, Pulmonary Fibrosis, Skin Exfoliation
on Jul 13, 2009 Female patient from UNITED STATES , 58 years of age, weighting 149.9 lb, was diagnosed with menopausal symptoms and was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: breast cancer (What is breast cancer?), pulmonary fibrosis (What is pulmonary fibrosis?), skin exfoliation. Climara dosage: .05 Mg/d, Cont. During the same period patient was treated with PREMARIN (1.25 Mg, Day 1-25 [daily Dose: 1.25 Mg]) (View Premarin Review and Premarin Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PROVERA (5 Mg, Day 16-25) (View Provera Review and Provera Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ).

6271781-X | Breast Cancer, Pulmonary Fibrosis, Skin Exfoliation
Patient was taking Climara (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?), pulmonary fibrosis (What is pulmonary fibrosis?), skin exfoliation on Jul 13, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 149.9 lb, was diagnosed with menopausal symptoms and. Climara dosage: .05 Mg/d, Cont. During the same period patient was treated with PREMARIN (1.25 Mg, Day 1-25 [daily Dose: 1.25 Mg]) (View Premarin Review and Premarin Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PROVERA (5 Mg, Day 16-25) (View Provera Review and Provera Label ), PREMPRO (Unk) (View Prempro Review and Prempro Label ).

6270185-3 | Hot Flush
Adverse event was reported on May 29, 2009 by a Female patient taking Climara (View Usage) (Dosage: Continuous Delivery For Once Weekly Application) was diagnosed with hypertension and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: hot flush. During the same period patient was treated with PILL FOR HIGH BLOOD PRESSURE (View Pill For High Blood Pressure Review and Pill For High Blood Pressure Label ).

6270183-X | Hot Flush
on Jun 03, 2009 Female patient from UNITED STATES , 58 years of age, was treated with Climara (View Usage). After Climara was administered, patient had the following side effects: hot flush. Climara dosage: Continuous Delivery For Once Weekly Application.

6268651-X | Application Site Rash, Rash Erythematous, Rash Pruritic
on Apr 21, 2009 Female patient from UNITED STATES , 51 years of age, weighting 145.5 lb, was diagnosed with menopausal symptoms and was treated with Climara (View Usage). Patient experienced the following unwanted or unexpected effects: application site rash, rash erythematous, rash pruritic. Climara dosage: Continuous Delivery For Once Weekly Application.

6268564-3 | Crying, Depression, Feeling Hot, Panic Attack
Patient was taking Climara (View Usage). Patient had the following side effects: crying, depression (What is depression?), feeling hot, panic attack on Apr 07, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with hysterectomy (What is hysterectomy?) and. Climara dosage: Continuous Delivery For Once Weekly Application.